Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
Go back to Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.62 +0.12 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.50 | 52 Week High | $45.34 | |||
| Open | $4.41 | 52 Week Low | $15.92 | |||
| Day High | $4.71 | P/E | 1.98 | |||
| Day Low | $4.39 | EPS | $2.33 | |||
| Volume | 741,305 | |||||
